Cargando…
In-vitro model to mimic T cell subset change in human PDAC organoid co-culture
PURPOSE: Immunotherapies have largely failed as treatment options for pancreatic ductal adenocarcinoma (PDAC). In this field, clinical translational studies into personalized treatment are of fundamental importance. In our study, we model tumor-cell immune-cell interactions in a co-culture of primar...
Autores principales: | Knoblauch, M., Ma, T., Beirith, I., Koch, D., Hofmann, F., Heinrich, K., Aghamaliev, U., Sirtl, S., Westphalen, C. B., Nieß, H., Reichert, M., Angele, M. K., Regel, I., Bazhin, A. V., Werner, J., Ilmer, M., Renz, Bernhard W. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Springer Berlin Heidelberg
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10587248/ https://www.ncbi.nlm.nih.gov/pubmed/37470855 http://dx.doi.org/10.1007/s00432-023-05100-7 |
Ejemplares similares
-
WNT enhancing signals in pancreatic cancer are transmitted by LGR6
por: Wang, Jing, et al.
Publicado: (2023) -
Identification of the Neurokinin-1 Receptor as Targetable Stratification Factor for Drug Repurposing in Pancreatic Cancer
por: Beirith, Iris, et al.
Publicado: (2021) -
Tigecycline causes loss of cell viability mediated by mitochondrial OXPHOS and RAC1 in hepatocellular carcinoma cells
por: Koch, Dominik T., et al.
Publicado: (2023) -
Pancreatic Ductal Adenocarcinoma (PDAC) Organoids: The Shining Light at the End of the Tunnel for Drug Response Prediction and Personalized Medicine
por: Frappart, Pierre-Olivier, et al.
Publicado: (2020) -
Combinatorial Effect of Magnetic Field and Radiotherapy in PDAC Organoids: A Pilot Study
por: Nicosia, Luca, et al.
Publicado: (2020)